{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T03:50:49Z","timestamp":1792900249076,"version":"4.5.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T00:00:00Z","timestamp":1595462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T00:00:00Z","timestamp":1595462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100011251","name":"Northern Ontario Academic Medicine Association","doi-asserted-by":"publisher","award":["A-17-05"],"award-info":[{"award-number":["A-17-05"]}],"id":[{"id":"10.13039\/100011251","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Due to the high prevalence of mental disorders among people with opioid use disorder, the objective of this study was to determine the association between concurrent mental disorders, mortality, morbidity, and continuous treatment retention for patients in opioid agonist treatment in Ontario, Canada.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study of patients enrolled in opioid agonist treatment between January 1, 2011, and December 31, 2015. Patients were stratified into two groups: those diagnosed with concurrent mental disorders and opioid use disorder and those with opioid use disorder only, using data from the Ontario Health Insurance Plan Database, Ontario Drug Benefit Plan Database. The primary outcome studied was all-cause mortality using data from the Registered Persons Database. Emergency department visits from the National Ambulatory Care Database, hospitalizations Discharge Abstract Database, and continuous retention in treatment, defined as 1\u2009year of uninterrupted opioid agonist treatment using data from the Ontario Drug Benefit Plan Database were measured as secondary outcomes. Encrypted patient identifiers were used to link information across databases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified 55,924 individuals enrolled in opioid agonist treatment, and 87% had a concurrent mental disorder diagnosis during this period. We observed that having a mental disorder was associated with an increased likelihood of all-cause mortality (odds ratio (OR) 1.4; 95% confidence interval (CI) 1.2\u20131.5). For patients diagnosed with mental disorders, the estimated rate of ED visits per year was 2.25 times higher and estimated rate of hospitalization per year was 1.67 times higher than for patients with no mental disorders. However, there was no association between having a diagnosis of a mental disorder and 1-year treatment retention in OAT-adjusted hazard ratio (HR) = 1.0; 95% CI 0.9 to 1.1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings highlight the consequences of the high prevalence of mental disorders for individuals with opioid use disorder in Ontario, Canada.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12954-020-00396-x","type":"journal-article","created":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T06:04:12Z","timestamp":1595484252000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["A cohort study evaluating the association between concurrent mental disorders, mortality, morbidity, and continuous treatment retention for patients in opioid agonist treatment (OAT) across Ontario, Canada, using administrative health data"],"prefix":"10.1186","volume":"17","author":[{"given":"Kristen A.","family":"Morin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph K.","family":"Eibl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Gauthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Rush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Mushquash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy E.","family":"Lightfoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8769-1785","authenticated-orcid":false,"given":"David C.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,23]]},"reference":[{"key":"396_CR1","unstructured":"Canadian Institute for Health Information: Pan-Canadian trends in the prescribing of opioids, 2012 to 2016 Ottawa ON 2017 [Available from: https:\/\/www.cihi.ca\/sites\/default\/files\/document\/pan-canadian-trends-opioid-prescribing-2017-en-web.pdf]."},{"issue":"3","key":"396_CR2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1755-5949.2008.00049.x","volume":"14","author":"M Van Ameringen","year":"2008","unstructured":"Van Ameringen M, Mancini C, Patterson B, Boyle MH. Post-traumatic stress disorder in Canada. CNS Neurosci Ther. 2008;14(3):171\u201381.","journal-title":"CNS Neurosci Ther"},{"key":"396_CR3","unstructured":"WHO. World Health Organization. Principles of drug dependence treatment Geneva, Switzerland: World Health Organization; 2008 [Available from: http:\/\/www.who.int\/substance_abuse\/publications\/principles_drug_dependence_treatment.pdf?ua=1]."},{"key":"396_CR4","unstructured":"Public Health Agency of Canada. Notice of intent to restrict the marketing and advertising of opioids Ottawa Ontario 2018 [Available from: https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/drug-products\/announcements\/restrict-advertising-opioids.html]."},{"issue":"23","key":"396_CR5","doi-asserted-by":"crossref","first-page":"E730","DOI":"10.1503\/cmaj.109-5612","volume":"190","author":"P Webster","year":"2018","unstructured":"Webster P. Oversight of opioid advertising in Canada remains lax despite new federal guidance. CMAJ. 2018;190(23):E730\u2013E1.","journal-title":"CMAJ."},{"issue":"5","key":"396_CR6","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1080\/10826080701204813","volume":"43","author":"M Astals","year":"2008","unstructured":"Astals M, Domingo-Salvany A, Buenaventura CC, Tato J, Vazquez JM, Martin-Santos R, et al. Impact of substance dependence and dual diagnosis on the quality of life of heroin users seeking treatment. Subst Use Misuse. 2008;43(5):612\u201332.","journal-title":"Subst Use Misuse"},{"key":"396_CR7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.drugalcdep.2014.12.025","volume":"148","author":"KM Bogdanowicz","year":"2015","unstructured":"Bogdanowicz KM, Stewart R, Broadbent M, Hatch SL, Hotopf M, Strang J, et al. Double trouble: psychiatric comorbidity and opioid addiction-all-cause and cause-specific mortality. Drug Alcohol Depend. 2015;148:85\u201392.","journal-title":"Drug Alcohol Depend"},{"key":"396_CR8","first-page":"157","volume":"40","author":"G MLD","year":"2015","unstructured":"MLD G, Dodd DR, Potter JS. Baseline characteristics and treatment outcomes in prescription opioid dependent patients with and without co-occurring psychiatric disorder. Am J Drug Alcohol Abuse. 2015;40:157\u201362.","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"8","key":"396_CR9","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/ajad.12292","volume":"24","author":"EC Saunders","year":"2015","unstructured":"Saunders EC, McGovern MP, Lambert-Harris C, Meier A, McLeman B, Xie H. The impact of addiction medications on treatment outcomes for persons with co-occurring PTSD and opioid use disorders. Am J Addict. 2015;24(8):722\u201331.","journal-title":"Am J Addict"},{"issue":"1","key":"396_CR10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archpsyc.1997.01830130077015","volume":"54","author":"RK Brooner","year":"1997","unstructured":"Brooner RK, King VL, Kidorf M, Schmidt CW Jr, Bigelow GE. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Arch Gen Psychiatry. 1997;54(1):71\u201380.","journal-title":"Arch Gen Psychiatry"},{"key":"396_CR11","doi-asserted-by":"crossref","unstructured":"Brannen CD, Dyck K, Hardy, C, Mushquash, C. Rural mental health services in Canda: a model for research and practice. In: Kulig JW, A., editor. Health in Rural Canada. Vancouver, BC, Canada: UBC Press; 2012. p. 239-255.","DOI":"10.59962\/9780774821742-016"},{"key":"396_CR12","unstructured":"Canadian Institute for Health Information. Canadian Population Health Initiative. How healthy are rural Canadians? An assessment of their health status and health determinants. Canadian Institute for Health Information; 2006."},{"key":"396_CR13","volume-title":"Short report#5: mental health in Northern Ontario","author":"M Ward","year":"2005","unstructured":"Ward M. Short report#5: mental health in Northern Ontario. Northern Health Information Partnership; 2005."},{"key":"396_CR14","unstructured":"Minore B, M. Boone, M.E. Hill, A. Lyubechansky, R. Kuzik, and C. Macdonald. Towards using family health teams to care for chronic mental health clients in Northern Ontario: Barriers, Opportunities and Training Needs. Centre for rural and Northern Health Research, Lakehead University; 2005."},{"key":"396_CR15","unstructured":"J. H. Rural health and the health of rural communities. 1998."},{"key":"396_CR16","unstructured":"World Health Organization: Prevention of mental disorders. Summary Report Geneva Switzerland: WHO; [Available from: http:\/\/www.who.int\/mental_health\/evidence\/en\/prevention_of_mental_disorders_sr.pdf]."},{"key":"396_CR17","first-page":"CD002209","volume":"3","author":"RP Mattick","year":"2009","unstructured":"Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. 2009;3:CD002209.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"396_CR18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jsat.2010.03.008","volume":"39","author":"B Nosyk","year":"2010","unstructured":"Nosyk B, Marsh DC, Sun H, Schechter MT, Anis AH. Trends in methadone maintenance treatment participation, retention, and compliance to dosing guidelines in British Columbia, Canada: 1996-2006. J Subst Abus Treat. 2010;39(1):22\u201331.","journal-title":"J Subst Abus Treat"},{"issue":"1","key":"396_CR19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.drugalcdep.2005.05.010","volume":"81","author":"J Bell","year":"2006","unstructured":"Bell J, Burrell T, Indig D, Gilmour S. Cycling in and out of treatment; participation in methadone treatment in NSW, 1990-2002. Drug Alcohol Depend. 2006;81(1):55\u201361.","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"396_CR20","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/aje\/kwg209","volume":"158","author":"N Galai","year":"2003","unstructured":"Galai N, Safaeian M, Vlahov D, Bolotin A, Celentano DD, Study A. Longitudinal patterns of drug injection behavior in the ALIVE study cohort,1988-2000: description and determinants. Am J Epidemiol. 2003;158(7):695\u2013704.","journal-title":"Am J Epidemiol"},{"issue":"4","key":"396_CR21","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jsat.2005.08.002","volume":"29","author":"A Dobler-Mikola","year":"2005","unstructured":"Dobler-Mikola A, Hattenschwiler J, Meili D, Beck T, Boni E, Modestin J. Patterns of heroin, cocaine, and alcohol abuse during long-term methadone maintenance treatment. J Subst Abus Treat. 2005;29(4):259\u201365.","journal-title":"J Subst Abus Treat"},{"issue":"3","key":"396_CR22","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/BF02287318","volume":"30","author":"G Bovasso","year":"2003","unstructured":"Bovasso G, Cacciola J. The long-term outcomes of drug use by methadone maintenance patients. J Behav Health Serv Res. 2003;30(3):290\u2013303.","journal-title":"J Behav Health Serv Res"},{"issue":"2","key":"396_CR23","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.drugalcdep.2005.01.013","volume":"79","author":"F Termorshuizen","year":"2005","unstructured":"Termorshuizen F, Krol A, Prins M, Geskus R, van den Brink W, van Ameijden EJ. Prediction of relapse to frequent heroin use and the role of methadone prescription: an analysis of the Amsterdam Cohort Study among drug users. Drug Alcohol Depend. 2005;79(2):231\u201340.","journal-title":"Drug Alcohol Depend"},{"key":"396_CR24","unstructured":"Hedegaard H, Warner, M., Mini\u00f1o, A. M. Drug overdose deaths in the United States, 1999\u20132016 NCHS Data Brief No. 294 2017 [Available from: https:\/\/www.cdc.gov\/nchs\/products\/databriefs\/db294.htm]."},{"key":"396_CR25","unstructured":"Public Health Agency of Canada. Statement from the co-chairs of the Special Advisory Committee on the Epidemic of Opioid Overdoses on Updates to Opioid-Related Mortality Data. Ottawa, ON 2018 [Available from: https:\/\/www.canada.ca\/en\/public-health\/news\/2018\/03\/statement-from-the-co-chairs-of-thespecial-advisory-committee-on-the-epidemic-of-opioid-o.html]."},{"key":"396_CR26","doi-asserted-by":"crossref","unstructured":"Gomes TGS, Martins D. Latest trends in opioid-related deaths in Ontario: 1991 to 2015 Toronto: Ontario Drug Policy Research Network; 2017 [Available from: http:\/\/odprn.ca\/wp-content\/uploads\/2017\/04\/ODPRN-Report_Latest-trends-in-opioid-related-deaths.pdf].","DOI":"10.31027\/ODPRN.2017.01"},{"key":"396_CR27","unstructured":"Martins DGS, Tadrous M, Paterson M, Bandola D, Singh S, Juurlink D, Mamdani M, Gomes T. Opioid use and related adverse events in Ontario. Ontario Drug Policy Research Network Toronto Ontario: ODPRN; 2016 [Available from: http:\/\/odprn.ca\/wp-content\/uploads\/2016\/11\/ODPRN-Opioid-Use-and-Related-Adverse-Events-Nov-2016.pdf]."},{"key":"396_CR28","unstructured":"Canadian Institute for Health Information, Canadian Centre on Substance Abuse. Hospitalizations and emergency department visits due to opioid poisoning in Canada. Ottawa ON: CIHI; 2016 [Available from: https:\/\/secure.cihi.ca\/free_products\/Opioid%20Poisoning%20Report%20%20EN.pdf]."},{"key":"396_CR29","unstructured":"Kingston Frontenac and Addington Public Health Unit Kingston, Ontario, Canada: KFL&A Public Health Informatics [Available from: https:\/\/public.tableau.com\/profile\/kflaphi#!\/vizhome\/OntarioOpioidSurveillanceMonitor\/ACESEDVisits]."},{"key":"396_CR30","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1192\/bjp.178.2.145","volume":"178","author":"G Andrews","year":"2001","unstructured":"Andrews G, Henderson S, Hall W. Prevalence, comorbidity, disability and service utilisation. Overview of the Australian National Mental Health Survey. Br J Psychiatry. 2001;178:145\u201353.","journal-title":"Br J Psychiatry"},{"key":"396_CR31","first-page":"CD004147","volume":"10","author":"L Amato","year":"2011","unstructured":"Amato L, Minozzi S, Davoli M, Vecchi S. Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence. Cochrane Database Syst Rev. 2011;10:CD004147.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"396_CR32","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/ADM.0000000000000193","volume":"10","author":"K Dugosh","year":"2016","unstructured":"Dugosh K, Abraham A, Seymour B, McLoyd K, Chalk M, Festinger D. A systematic review on the use of psychosocial interventions in conjunction with medications for the treatment of opioid addiction. J Addict Med. 2016;10(2):91\u2013101.","journal-title":"J Addict Med"},{"issue":"2","key":"396_CR33","first-page":"137","volume":"63","author":"S Mamakwa","year":"2017","unstructured":"Mamakwa S, Kahan M, Kanate D, Kirlew M, Folk D, Cirone S, et al. Evaluation of 6 remote First Nations community-based buprenorphine programs in northwestern Ontario: retrospective study. Can Fam Physician. 2017;63(2):137\u201345.","journal-title":"Can Fam Physician"},{"issue":"9","key":"396_CR34","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1111\/add.12598","volume":"109","author":"T Gomes","year":"2014","unstructured":"Gomes T, Mamdani MM, Dhalla IA, Cornish S, Paterson JM, Juurlink DN. The burden of premature opioid-related mortality. Addiction. 2014;109(9):1482\u20138.","journal-title":"Addiction."},{"issue":"1","key":"396_CR35","doi-asserted-by":"crossref","first-page":"22","DOI":"10.12927\/hcq.2011.22153","volume":"14","author":"T Gomes","year":"2011","unstructured":"Gomes T, Juurlink D, Moineddin R, Gozdyra P, Dhalla I, Paterson M, et al. Geographical variation in opioid prescribing and opioid-related mortality in Ontario. Healthcare Quarterly. 2011;14(1):22\u20134.","journal-title":"Healthcare Quarterly"},{"issue":"3","key":"396_CR36","first-page":"92","volume":"20","author":"N Kiepek","year":"2015","unstructured":"Kiepek N, Groom B, Toppozini D, Kakekagumick K, Muileboom J, Kelly L. Evaluation of an inpatient medical withdrawal program in rural Ontario: a 1-year prospective study. Can J Rural Med. 2015;20(3):92\u20137.","journal-title":"Can J Rural Med"},{"key":"396_CR37","unstructured":"Volkow ND. America\u2019s addiction to opioids: heroin and prescription drug abuse [Available from: https:\/\/www.nih.gov\/sites\/default\/files\/institutes\/olpa\/20140514-senate-testimony-volkow.pdf]."},{"issue":"6","key":"396_CR38","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/aje\/kwp186","volume":"170","author":"B Nosyk","year":"2009","unstructured":"Nosyk B, MacNab YC, Sun H, Fischer B, Marsh DC, Schechter MT, et al. Proportional hazards frailty models for recurrent methadone maintenance treatment. Am J Epidemiol. 2009;170(6):783\u201392.","journal-title":"Am J Epidemiol"},{"issue":"3","key":"396_CR39","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1590\/S1135-57272008000300002","volume":"82","author":"E von Elm","year":"2008","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Rev Esp Salud Publica. 2008;82(3):251\u20139.","journal-title":"Rev Esp Salud Publica"},{"issue":"6","key":"396_CR40","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/ADM.0000000000000156","volume":"9","author":"JK Eibl","year":"2015","unstructured":"Eibl JK, Gomes T, Martins D, Camacho X, Juurlink DN, Mamdani MM, et al. Evaluating the effectiveness of first-time methadone maintenance therapy across northern, rural, and urban regions of Ontario. Canada J Addict Med. 2015;9(6):440\u20136.","journal-title":"Canada J Addict Med"},{"key":"396_CR41","unstructured":"Ministry of Health and Long Term Care. Opioid Agonist Maintenance Program (OAMP) monthly management fee and point of care drug testing health services Branch; 2012 [Available from: http:\/\/www.health.gov.on.ca\/en\/pro\/programs\/ohip\/bulletins\/4000\/bul4548.pdf]."},{"issue":"4","key":"396_CR42","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/archinte.163.4.481","volume":"163","author":"M Mamdani","year":"2003","unstructured":"Mamdani M, Rochon P, Juurlink DN, Anderson GM, Kopp A, Naglie G, et al. Effect of selective cyclooxygenase 2 inhibitors and naproxen on short-term risk of acute myocardial infarction in the elderly. Arch Intern Med. 2003;163(4):481\u20136.","journal-title":"Arch Intern Med"},{"issue":"23","key":"396_CR43","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1161\/CIRCULATIONAHA.109.907295","volume":"120","author":"DN Juurlink","year":"2009","unstructured":"Juurlink DN. Proton pump inhibitors and clopidogrel: putting the interaction in perspective. Circulation. 2009;120(23):2310\u20132.","journal-title":"Circulation."},{"key":"396_CR44","doi-asserted-by":"crossref","first-page":"b2942","DOI":"10.1136\/bmj.b2942","volume":"339","author":"DN Juurlink","year":"2009","unstructured":"Juurlink DN, Gomes T, Lipscombe LL, Austin PC, Hux JE, Mamdani MM. Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study. BMJ. 2009;339:b2942.","journal-title":"BMJ."},{"issue":"3","key":"396_CR45","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s001270050194","volume":"35","author":"P McConville","year":"2000","unstructured":"McConville P, Walker NP. The reliability of case register diagnoses: a birth cohort analysis. Soc Psychiatry Psychiatr Epidemiol. 2000;35(3):121\u20137.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"22","key":"396_CR46","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1001\/archinte.165.22.2631","volume":"165","author":"SM Frayne","year":"2005","unstructured":"Frayne SM, Halanych JH, Miller DR, Wang F, Lin H, Pogach L, et al. Disparities in diabetes care: impact of mental illness. Arch Intern Med. 2005;165(22):2631\u20138.","journal-title":"Arch Intern Med"},{"issue":"1","key":"396_CR47","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/1062860609346347","volume":"25","author":"SM Frayne","year":"2010","unstructured":"Frayne SM, Miller DR, Sharkansky EJ, Jackson VW, Wang F, Halanych JH, et al. Using administrative data to identify mental illness: what approach is best? Am J Med Qual. 2010;25(1):42\u201350.","journal-title":"Am J Med Qual"},{"key":"396_CR48","unstructured":"Mental Health Commission of Canada. Overview of mental health data in Canada: background, needs, and gaps, Calgary, AB 2014 [Available from: www.mentalhealthcommission.ca."},{"issue":"6","key":"396_CR49","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/gps.1527","volume":"21","author":"M Sajatovic","year":"2006","unstructured":"Sajatovic M, Blow FC, Ignacio RV. Psychiatric comorbidity in older adults with bipolar disorder. Int J Geriatr Psychiatry. 2006;21(6):582\u20137.","journal-title":"Int J Geriatr Psychiatry"},{"key":"396_CR50","unstructured":"Durbin J LE, Rush B. A study of hospital emergency service use, crisis service delivery and police response after mental health system enhancements. 2010."},{"issue":"7","key":"396_CR51","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/0277-9536(87)90040-2","volume":"25","author":"K Genell Andren","year":"1987","unstructured":"Genell Andren K, Rosenqvist U. Heavy users of an emergency department--a two year follow-up study. Soc Sci Med. 1987;25(7):825\u201331.","journal-title":"Soc Sci Med"},{"issue":"1","key":"396_CR52","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.annemergmed.2011.03.007","volume":"58","author":"F Althaus","year":"2011","unstructured":"Althaus F, Paroz S, Hugli O, Ghali WA, Daeppen JB, Peytremann-Bridevaux I, et al. Effectiveness of interventions targeting frequent users of emergency departments: a systematic review. Ann Emerg Med. 2011;58(1):41\u201352 e42.","journal-title":"Ann Emerg Med"},{"issue":"4","key":"396_CR53","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/10550880802324382","volume":"27","author":"E Peles","year":"2008","unstructured":"Peles E, Linzy S, Kreek M, Adelson M. One-year and cumulative retention as predictors of success in methadone maintenance treatment: a comparison of two clinics in the United States and Israel. J Addict Dis. 2008;27(4):11\u201325.","journal-title":"J Addict Dis"},{"issue":"1","key":"396_CR54","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12954-017-0134-5","volume":"14","author":"AM Franklyn","year":"2017","unstructured":"Franklyn AM, Eibl JK, Gauthier G, Pellegrini D, Lightfoot NK, Marsh DC. The impact of benzodiazepine use in patients enrolled in opioid agonist therapy in Northern and rural Ontario. Harm Reduct J. 2017;14(1):6.","journal-title":"Harm Reduct J"},{"key":"396_CR55","volume-title":"A unified approach to measuring the effect size between two groups using SAS","author":"DDJ Yang","year":"2012","unstructured":"Yang D DJ. A unified approach to measuring the effect size between two groups using SAS 2012 [Available from: https:\/\/support.sas.com\/resources\/papers\/proceedings12\/335-2012.pdf]."},{"issue":"3","key":"396_CR56","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar Behav Res. 2011;46(3):399\u2013424.","journal-title":"Multivar Behav Res"},{"issue":"3","key":"396_CR57","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00787-010-0087-7","volume":"19","author":"M Szumilas","year":"2010","unstructured":"Szumilas M. Explaining odds ratios. J Can Acad Child Adolesc Psychiatry. 2010;19(3):227\u20139.","journal-title":"J Can Acad Child Adolesc Psychiatry"},{"key":"396_CR58","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-227X-11-13","volume":"11","author":"R Moineddin","year":"2011","unstructured":"Moineddin R, Meaney C, Agha M, Zagorski B, Glazier RH. Modeling factors influencing the demand for emergency department services in Ontario: a comparison of methods. BMC Emerg Med. 2011;11:13.","journal-title":"BMC Emerg Med"},{"key":"396_CR59","unstructured":"Pedan, A.. Analysis of count data using the SAS\u00aeSystem Tewksbury, MA SAS; [Available from: https:\/\/support.sas.com\/resources\/papers\/proceedings\/proceedings\/sugi26\/p247-26.pdf."},{"key":"396_CR60","unstructured":"SAS version 9.4 Cary, North Carolina [Available from: https:\/\/www.sas.com\/en_us\/software\/sas9.html]."},{"issue":"11","key":"396_CR61","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.3390\/ijerph6112822","volume":"6","author":"M Astals","year":"2009","unstructured":"Astals M, Diaz L, Domingo-Salvany A, Martin-Santos R, Bulbena A, Torrens M. Impact of co-occurring psychiatric disorders on retention in a methadone maintenance program: an 18-month follow-up study. Int J Environ Res Public Health. 2009;6(11):2822\u201332.","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"396_CR62","first-page":"126","volume":"43","author":"M Gelkopf","year":"2006","unstructured":"Gelkopf M, Weizman T, Melamed Y, Adelson M, Bleich A. Does psychiatric comorbidity affect drug abuse treatment outcome? A prospective assessment of drug abuse, treatment tenure and infectious diseases in an Israeli methadone maintenance clinic. Isr J Psychiatry Relat Sci. 2006;43(2):126\u201336.","journal-title":"Isr J Psychiatry Relat Sci"},{"issue":"6","key":"396_CR63","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1001\/archpsyc.1983.04390010030004","volume":"40","author":"ATL McLellan","year":"1983","unstructured":"McLellan ATL, Luborsky L, Woody GE, O\u2019Brien CP, Druley KA. Predicting response to alcohol and drug abuse treatments. Role of psychiatric severity. Arch Gen Psychiatry. 1983;40(6):620\u20135.","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"396_CR64","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000081412","volume":"11","author":"U Verthein","year":"2005","unstructured":"Verthein U, Degkwitz P, Haasen C, Krausz M. Significance of comorbidity for the long-term course of opiate dependence. Eur Addict Res. 2005;11(1):15\u201321.","journal-title":"Eur Addict Res"},{"key":"396_CR65","doi-asserted-by":"crossref","unstructured":"Saunders EC, McGovern MP, Lambert-Harris C, Meier A, McLeman B, Xie H. The impact of addiction medications on treatment outcomes for persons with co-occurring PTSD and opioid use disorders. Am J Addict. 2015.","DOI":"10.3109\/14659891.2015.1005184"},{"issue":"2","key":"396_CR66","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00005053-199802000-00004","volume":"186","author":"BJ Rounsaville","year":"1998","unstructured":"Rounsaville BJ, Kranzler HR, Ball S, Tennen H, Poling J, Triffleman E. Personality disorders in substance abusers: relation to substance use. J Nerv Ment Dis. 1998;186(2):87\u201395.","journal-title":"J Nerv Ment Dis"},{"issue":"5","key":"396_CR67","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1001\/archpsyc.58.5.503","volume":"58","author":"YI Hser","year":"2001","unstructured":"Hser YI, Hoffman V, Grella CE, Anglin MD. A 33-year follow-up of narcotics addicts. Arch Gen Psychiatry. 2001;58(5):503\u20138.","journal-title":"Arch Gen Psychiatry"},{"issue":"12 Pt 2","key":"396_CR68","first-page":"9","volume":"45","author":"CP O'Brien","year":"1984","unstructured":"O'Brien CP, Woody GE, McLellan AT. Psychiatric disorders in opioid-dependent patients. J Clin Psychiatry. 1984;45(12 Pt 2):9\u201313.","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"396_CR69","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jsat.2013.02.008","volume":"45","author":"J Gryczynski","year":"2013","unstructured":"Gryczynski J, Mitchell SG, Jaffe JH, Kelly SM, Myers CP, O'Grady KE, et al. Retention in methadone and buprenorphine treatment among African Americans. J Subst Abus Treat. 2013;45(3):287\u201392.","journal-title":"J Subst Abus Treat"},{"issue":"1","key":"396_CR70","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/add.12333","volume":"109","author":"YI Hser","year":"2014","unstructured":"Hser YI, Saxon AJ, Huang D, Hasson A, Thomas C, Hillhouse M, et al. Treatment retention among patients randomized to buprenorphine\/naloxone compared to methadone in a multi-site trial. Addiction. 2014;109(1):79\u201387.","journal-title":"Addiction."},{"key":"396_CR71","unstructured":"Agency of Health Protection and Promotion. Opioid related morbidity and mortality Toronto Ontario [Available from: https:\/\/www.publichealthontario.ca\/en\/dataandanalytics\/pages\/opioid.aspx#\/drug]."},{"key":"396_CR72","unstructured":"Opioid-related morbidity and mortality in Ontario [Internet] 2017 [Available from: https:\/\/www.publichealthontario.ca\/en\/dataandanalytics\/pages\/opioid.aspx#\/trends."},{"issue":"3","key":"396_CR73","first-page":"e87","volume":"8","author":"P Kurdyak","year":"2014","unstructured":"Kurdyak P, Stukel TA, Goldbloom D, Kopp A, Zagorski BM, Mulsant BH. Universal coverage without universal access: a study of psychiatrist supply and practice patterns in Ontario. Open Med. 2014;8(3):e87\u201399.","journal-title":"Open Med"},{"key":"396_CR74","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s12888-016-0963-x","volume":"16","author":"KA Davis","year":"2016","unstructured":"Davis KA, Sudlow CL, Hotopf M. Can mental health diagnoses in administrative data be used for research? A systematic review of the accuracy of routinely collected diagnoses. BMC Psychiatry. 2016;16:263.","journal-title":"BMC Psychiatry"},{"issue":"2","key":"396_CR75","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s11414-011-9263-x","volume":"39","author":"EC Meltzer","year":"2012","unstructured":"Meltzer EC, Averbuch T, Samet JH, Saitz R, Jabbar K, Lloyd-Travaglini C, et al. Discrepancy in diagnosis and treatment of post-traumatic stress disorder (PTSD): treatment for the wrong reason. J Behav Health Serv Res. 2012;39(2):190\u2013201.","journal-title":"J Behav Health Serv Res"},{"key":"396_CR76","unstructured":"Nutt DS, M, Zohar, J. Post traumatic stress disorder: diagnosis, management and treatment: CRC Press; 2009."},{"issue":"3","key":"396_CR77","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0272-7358(98)00107-X","volume":"20","author":"D Weinstein","year":"2000","unstructured":"Weinstein D, Staffelbach D, Biaggio M. Attention-deficit hyperactivity disorder and posttraumatic stress disorder: differential diagnosis in childhood sexual abuse. Clin Psychol Rev. 2000;20(3):359\u201378.","journal-title":"Clin Psychol Rev"},{"issue":"6","key":"396_CR78","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1037\/0735-7028.38.6.620","volume":"38","author":"KA Vickerman","year":"2007","unstructured":"Vickerman KA, Margolin G. Post-traumatic stress in children and adolescents exposed to family violence: II. Treatment Prof Psychol Res Pr. 2007;38(6):620.","journal-title":"Treatment Prof Psychol Res Pr"},{"issue":"3","key":"396_CR79","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3174\/ajnr.A2425","volume":"32","author":"O Naggara","year":"2011","unstructured":"Naggara O, Raymond J, Guilbert F, Roy D, Weill A, Altman DG. Analysis by categorizing or dichotomizing continuous variables is inadvisable: an example from the natural history of unruptured aneurysms. AJNR Am J Neuroradiol. 2011;32(3):437\u201340.","journal-title":"AJNR Am J Neuroradiol"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-020-00396-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-020-00396-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-020-00396-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T14:25:00Z","timestamp":1696429500000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-020-00396-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,23]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["396"],"URL":"https:\/\/doi.org\/10.1186\/s12954-020-00396-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-27508\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-19301\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-27508\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-27508\/v1","asserted-by":"object"}]},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,23]]},"assertion":[{"value":"6 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Research Ethics Board of Laurentian University in Sudbury, Ontario, Canada.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This study only used administrative health data, there was no primary data collection; therefore, consent for publication from individual patients did not apply.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. David Marsh maintains the following roles: Chief Medical Director at CATC (Canadian Addiction Treatment Center), opioid agonist therapy provider. Dr. Marsh has no ownership stake in the CATC as a stipendiary employee. We do not foresee any conflict of interest as data will be made freely available to the public, and neither the CATC nor the Universities prevent publication and dissemination of knowledge. The authors have no conflicts declared. This does not alter our adherence to the Harm Reduction Journal\u2019s policies on sharing data and materials","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}